Generation of HPMC-derived Placebo Hydrogel Component Matrix System for Possible Pharmaceutical 3D Printing Applications

Abstract

Integration of 3D bioprinting technology in the design and fabrication of pharmaceutical dosage form has the potential toovercome the limitations and expand the range of drugs that can be delivered through different routes. In recent years, thefield of bioprinting has emerged as a revolutionary technology with the potential to transform various aspects of the healthcareand pharmaceutical industries. Among its wide-ranging applications, one of the most promising areas is the development oftransdermal drug delivery systems using 3D bioprinting techniques. This innovative approach holds significant promise inenhancing drug delivery efficiency, improving patient compliance, and revolutionizing personalized medicine. 3D bioprintingtechnology offers exciting prospects for the development of transdermal patches specifically designed for wound healingapplications. With further advancements and research, these innovative patches have the potential to revolutionize the fieldof wound care and improve patient outcomes.